التفاصيل البيبلوغرافية
| العنوان: |
Bloodless Medicine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. |
| المؤلفون: |
McKiernan, Phyllis1, Baker, Eliana2, Baker, Melissa3 melissa.baker@hmhn.org |
| المصدر: |
Clinical Journal of Oncology Nursing. Oct2024, Vol. 28 Issue 5, p463-468. 6p. |
| مصطلحات موضوعية: |
*THROMBOCYTOPENIA treatment, *CELL transplantation, *HEMORRHAGE prevention, *HEMATOPOIETIC stem cell transplantation, *TRANSFUSION-free surgery, *CONTINUING education units, *HEMATOPOIETIC agents, *AMINOCAPROIC acids, *PATIENT safety, *TRANSPLANTATION of organs, tissues, etc., *HEMOGLOBINS, *HOMOGRAFTS, *SURGICAL blood loss, *DESMOPRESSIN, *RELIGION, *ABO blood group system, *BLOOD grouping & crossmatching, *IMMUNOSUPPRESSION, *HEALTH care teams |
| مستخلص: |
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (alloHSCT) poses challenges for patients who decline blood products because of religious beliefs or other reasons. Despite potential curative prospects, many institutions refrain from offering alloHSCT to patients who decline blood products because of safety concerns associated with cytopenias. OBJECTIVES: This review focuses on one institution's experience of conducting alloHSCT without blood components, emphasizing preparation and supportive care. METHODS: The approach of conducting alloHSCT without blood components, which involves ABO-compatible donor matching, nonmyeloablative regimens, and pretransplantation optimization of red blood cell production, is discussed. FINDINGS: The clinical team can minimize transfusion needs by using erythropoiesis-stimulating agents, thrombopoietin agonists, and peri- and post-transplantation management strategies. These recommendations can ensure patient safety and successful outcomes with bloodless medicine. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |